ArticleMolecular therapy. Oncology2025

Intravesical VSVd51-GM-CSF virotherapy is superior to BCG in treating bladder cancer in preclinical and translational models.

Lauren Daniel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.